• Flemish researchers launch OPENPichia, an industrial open access yeast system for the production of proteins

    Wednesday March 6th 2024

  • Mithra announces changes to its executive management

    Tuesday March 5th 2024

  • Tom Plitz commences role as Chief Executive Officer of Precirix

    Friday March 1st 2024

  • Newly discovered protein blocks sleeping sickness

    Wednesday February 28th 2024

  • DONESTA® safety study for menopause completes treatment phase and advances to data management & reporting phase

    Wednesday February 28th 2024

  • RheumaFinder announces investment by Novalis Biotech to revolutionize care for patients with rheumatic diseases

    Tuesday February 27th 2024

  • VUB research team discovers essential protein that contributes to liver fibrosis

    Friday February 23rd 2024

  • Rejuvenate Biomed’s clinical trial demonstrates the therapeutic potential of RJx-01 in sarcopenia

    Wednesday February 21st 2024

  • Your news here?

  • Altavo concludes Series A for the development of its Artificial Voice

    Tuesday February 20th 2024

  • argenx announces FDA acceptance of supplemental Biologics License Application with priority review for VYVGART Hytrulo in chronic inflammatory demyelinating polyneuropathy

    Tuesday February 20th 2024

  • Mithra sells shares in Mayne Pharma

    Thursday February 15th 2024


Strategic Partners